| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0007 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0009 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0009 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0009 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |